Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
avapritinib
2
×
biotech
blueprint medicines
boston blog main
boston top stories
cancer
2
×
eli lilly
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
2
×
aimmune therapeutics
alopecia areata
amarin
arena pharmaceuticals
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
cadent therapeutics
cancer drugs
cancer immunotherapy
capmatinib
celgene
centers for disease control and prevention
centrexion therapeutics
clinical trials
colucid pharmaceuticals
concert pharmaceuticals
detroit blog main
detroit top stories
dragonfly therapeutics
esophageal cancer
europe blog main
europe top stories
fda
galcanezumab
What
address
approval
approves
arena’s
bio
blueprint
bounty
cancer
carries
certain
cig
comeback
companies
corner
deals
delivered
designed
drug
expressing
fda
genetic
ipo
latest
life
little
medicines
moderna’s
number
pass
ret
roundup
science
signature
signatures
survey
targeted
targeting
thanks
thanksgiving
therapy
Language
unset
Current search:
avapritinib
×
cancer
×
" san francisco top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More